FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gilles Edan

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

France

Physiology

Genes & Molecular Sequences

Alleles

Procedures

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Emmanuelle Leray; J Oger; Jacqueline Yaouanq; Marc Coustans; Emmanuelle Le Page; Gilles Edan
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Yves Denoyer; Gilles Edan; France Woimant; Muriel Bost; Sophie Drapier
Neurological Wilson's disease lethal for the son, asymptomatic in the father.
Gilles Edan
There is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gilles Edan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emmanuelle Leray; J Oger; Jacqueline Yaouanq; Marc Coustans; Emmanuelle Le Page; Gilles Edan
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(4):458-65.
2013: Yves Denoyer; Gilles Edan; France Woimant; Muriel Bost; Sophie Drapier
Neurological Wilson's disease lethal for the son, asymptomatic in the father.
Movement disorders : official journal of the Movement Disorder Society 2013;28(3):402-3.
2012: Gilles Edan
There is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(7):927-9.
2012: dimitri renard; Emmanuel Touze; Sandra Vukusic; Hélène Zephyr; Odile Boespflug-Tanguy; Bruno Brochet; Giovanni Castelnovo; Alain Creange; Véronique Deburghgraeve; Romain Deschamps; Diane Dupuy; Gilles Edan; Cyril Goizet; Pierre Labauge
Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions.
European neurology 2012;68(3):156-61.
2011: S Acaster; B Arnason; K Beckmann; G Comi; S Cook; Gilles Edan; M Filippi; M Freedman; K Gondek; Hans-Peter Hartung; D Jeffery; Ludwig Kappos; Volker Knappertz; Paul O'Connor; Christoph Pohl; Rupert Sandbrink; B Stemper; P Swinburn; C Wang; A J Lloyd
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(12):1504-13.
2011: A Kerbrat; François Lallement; David Laplaud; Emmanuelle Le Page; Emmanuelle Leray; F Rouhart; E Sartori; R Wardi; Sandrine Wiertlewski; T Anani; Marc Coustans; C Desormeaux; P Diraison; C Guiziou; P Kassiotis; Gilles Edan
Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients.
Journal of the neurological sciences 2011;308(1-2):98-102.
2011: Hans-Peter Hartung; Ludwig Kappos; Volker Knappertz; V Lanius; David H Miller; Xavier Montalbán; John Petkau; C Pohl; Chris H Polman; V Sahajpal; Rupert Sandbrink; Rick White; Frederik Barkhof; Karola Beckmann; Gilles Edan; Mark S Freedman
Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome.
Neurology 2011;77(9):835-43.
2011: Ludwig Kappos; David Bates; Michel Clanet; David B Clifford; Gilles Edan; Mefkûre Eraksoy; Antonio Garcia-Merino; Ralf Gold; Nikolaos Grigoriadis; Hans-Peter Hartung; Stephen Hauser; Eva Havrdová; Jan Hillert; Hans H Hirsch; Reinhard Hohlfeld; Marcelo Kremenchutzky; Olivier Lyon-Caen; Eugene O Major; Ariel Miller; Paul W O'Connor; Carlo Pozzilli; Ernst W Radü; Mads Ravnborg; Takahiko Saida; Christian Sindic; Per Soelberg Sørensen; Karl Vass; Howard L Weiner; John King
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Lancet neurology 2011;10(8):745-58.
2011: Emmanuelle Le Page; Emmanuelle Leray; Gilles Edan
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(7):867-75.
2011: Nicolas Couturier; Florence Bucciarelli; Ramil N Nurtdinov; Marc Debouverie; Christine Lebrun-Frenay; Gilles Defer; Thibault Moreau; Christian Confavreux; Sandra Vukusic; Isabelle Cournu-Rebeix; Robert H Goertsches; Uwe K Zettl; Manuel Comabella; Xavier Montalban; Peter Rieckmann; Frank Weber; Bertram Müller-Myhsok; Gilles Edan; Bertrand Fontaine; Lennart T Mars; Abdelhadi Saoudi; Jorge R Oksenberg; Michel Clanet; Roland S Liblau; David Brassat
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Brain : a journal of neurology 2011;134(Pt 3):693-703.
2010: T Rouaud; P Labauge; E Tournier Lasserve; M Mine; Marc Coustans; V Deburghgraeve; Gilles Edan
Acute urinary retention due to a novel collagen COL4A1 mutation.
Neurology 2010;75(8):747-9.
2010: Emmanuelle Leray; Jacqueline Yaouanq; Emmanuelle Le Page; Marc Coustans; David Laplaud; Joël Oger; Gilles Edan
Evidence for a two-stage disability progression in multiple sclerosis.
Brain : a journal of neurology 2010;133(Pt 7):1900-13.
2010: D Videt-Gibou; Serge Belliard; J Rivalan; D Ménard; Gilles Edan
[Acquired copper deficiency myelopathy].
Revue neurologique 2010;166(6-7):639-43.
2009: Bastiaan Moraal; Christoph Pohl; Bernard M J Uitdehaag; Chris H Polman; Gilles Edan; Mark S Freedman; Hans-Peter Hartung; Ludwig Kappos; David H Miller; Xavier Montalban; Vivian Lanius; Rupert Sandbrink; Frederik Barkhof
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
Archives of neurology 2009;66(11):1345-52.
2009: Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederik Barkhof; Ernst W Radü; Carola Metzig; Lars Bauer; Vivian Lanius; Rupert Sandbrink; Christoph Pohl
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Lancet neurology 2009;8(11):987-97.
2009: Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.
European journal of human genetics : EJHG 2009;17(6):844-7.
2009: Hélène Massé; Jean-Laurent Guyomard; Dominique Baudet; Jean-François Pinel; Gilles Edan; Jean-François Charlin
Mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis.
Case reports in medicine 2009;2009():481512.
2009: Jessica M Nielsen; Christoph Pohl; Chris H Polman; Frederik Barkhof; Mark S Freedman; Gilles Edan; David H Miller; Lars Bauer; Rupert Sandbrink; Ludwig Kappos; Bernard M J Uitdehaag
MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome.
BMC neurology 2009;9():19.
2008: Catherine Massart; Jacqueline Gibassier; Jérôme de Seze; Marc Debouverie; Thibault Moreau; Jean Pelletier; Patrick Vermersch; Gilles Edan
Determination of interferon beta neutralizing antibodies in multiple sclerosis: improvement of clinical sensitivity of a cytopathic effect assay.
Clinica chimica acta; international journal of clinical chemistry 2008;391(1-2):98-101.
2008: Chris Polman; Ludwig Kappos; Mark S Freedman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederick Barkhof; Krzysztof Selmaj; Bernard Uitdehaag; Susanne Dahms; Lars Bauer; Christoph Pohl; Rupert Sandbrink
Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.
Journal of neurology 2008;255(4):480-7.
2008: Aaron Boster; Gilles Edan; Elliot M Frohman; Adil Javed; Olaf Stuve; Alexandros Tselis; Howard L Weiner; Bianca Weinstock-Guttman; OA Khan
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.
Lancet neurology 2008;7(2):173-83.
2008: Emmanuelle Le Page; Emmanuelle Leray; Grégory Taurin; Marc Coustans; Jacques Chaperon; Sean P Morrissey; Gilles Edan
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Journal of neurology, neurosurgery, and psychiatry 2008;79(1):52-6.
2007: Jérôme de Seze; Marc Debouverie; Hélène Zephir; Christine Lebrun; Frédéric Blanc; Véronique Bourg; Sandrine Wiertlewski; Sophie Pittion; David Laplaud; Emmanuelle Le Page; Romain Deschamps; Philippe Cabre; Jean Pelletier; Irina Malikova; Pierre Clavelou; Valérie Jaillon; Gilles Defer; Pierre Labauge; Olivier Gout; Clotilde Boulay; Gilles Edan; Patrick Vermersch
Acute fulminant demyelinating disease: a descriptive study of 60 patients.
Archives of neurology 2007;64(10):1426-32.
2007: Frederik Barkhof; Chris H Polman; Ernst-Wilhelm Radue; Ludwig Kappos; Mark S Freedman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Peter A Poppe; Marlieke de Vos; Fatiha Lasri; Lars Bauer; Susanne Dahms; Klaus Wagner; Christoph Pohl; Rupert Sandbrink
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Archives of neurology 2007;64(9):1292-8.
2007: Ludwig Kappos; Mark S Freedman; Chris H Polman; Gilles Edan; Hans-Peter Hartung; David H Miller; Xavier Montalbán; Frederik Barkhof; Ernst W Radü; Lars Bauer; Susanne Dahms; Vivian Lanius; Christoph Pohl; Rupert Sandbrink
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.
Lancet 2007;370(9585):389-97.
2007: Emmanuelle Leray; Sean P Morrissey; Jacqueline Yaouanq; Marc Coustans; Emmanuelle Le Page; Jacques Chaperon; Gilles Edan
Long-term survival of patients with multiple sclerosis in West France.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(7):865-74.
2007: Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Natural history of multiple sclerosis with childhood onset.
The New England journal of medicine 2007;356(25):2603-13.
2007: Catherine Massart; Jacqueline Gibassier; Joël Oger; Emmanuelle Le Page; Gilles Edan
Neutralizing antibodies to interferon beta in multiple sclerosis: analytical evaluation for validation of a cytopathic effect assay.
Clinica chimica acta; international journal of clinical chemistry 2007;377(1-2):185-91.
2007: Jens Kuhle; Christoph Pohl; Matthias Mehling; Gilles Edan; Mark S Freedman; Hans-Peter Hartung; Chris H Polman; David H Miller; Xavier Montalban; Frederik Barkhof; Lars Bauer; Susanne Dahms; Raija L P Lindberg; Ludwig Kappos; Rupert Sandbrink
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
The New England journal of medicine 2007;356(4):371-8.
2006: Ludwig Kappos; Chris H Polman; Mark S Freedman; Gilles Edan; H P Hartung; David H Miller; Xavier Montalban; Frederik Barkhof; L Bauer; Peter Jakobs; C Pohl; Rupert Sandbrink
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Neurology 2006;67(7):1242-9.
2006: Dominique Drapier; Sophie Drapier; Paul Sauleau; Claire Haegelen; Sylvie Raoul; I Biseul; J Peron; François Lallement; Isabelle Rivier; Jean-Michel Reymann; Gilles Edan; Marc Verin; Bruno Millet
Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?
Journal of neurology 2006;253(8):1083-91.
2006: Emmanuelle Le Page; Gilles Edan
[Drug therapy in multiple sclerosis].
La Revue du praticien 2006;56(12):1336-46.
2006: Eric Sartori; Gilles Edan
Assessment of cognitive dysfunction in multiple sclerosis.
Journal of the neurological sciences 2006;245(1-2):169-75.
2006: Aurélie Durufle; Sabine Petrilli; Benoit Nicolas; Sandrine Robineau; François Guillé; Gilles Edan; Philippe Gallien
Effects of pregnancy and child birth on urinary symptoms and urodynamics in women with multiple sclerosis.
International urogynecology journal and pelvic floor dysfunction 2006;17(4):352-5.
2006: E Sartori; S Belliard; C Chevrier; P Trebon; Jacques Chaperon; Gilles Edan
[From psychometry to neuropsychological disability in multiple sclerosis: a new brief French cognitive screening battery and cognitive risk factors].
Revue neurologique 2006;162(5):603-15.
2006: Emmanuelle Le Page; Emmanuelle Leray; Grégory Taurin; Marc Coustans; Jacques Chaperon; Gilles Edan
[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients].
Revue neurologique 2006;162(2):185-94.
2006: Valérie Kerdoncuff; Aurélie Durufle; Hélène Le Tallec; A Lassalle; Sabine Petrilli; Benoit Nicolas; Sandrine Robineau; Gilles Edan; Philippe Gallien
[Multiple sclerosis and physical activities].
Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique 2006;49(1):32-6.
2006: Aurélie Durufle; Benoit Nicolas; Sabine Petrilli; Sandrine Robineau; François Guillé; Gilles Edan; Philippe Gallien
Effects of pregnancy and childbirth on the incidence of urinary disorders in multiple sclerosis.
Clinical and experimental obstetrics & gynecology 2006;33(4):215-8.
2006: Marc Cuggia; Nicolas Herry; Delphine Rossille; Emmanuelle Lepage; Gilles Edan; Pierre Le Beux
A model for a regional health information network sharing clinical information between professionals in Britanny.
Studies in health technology and informatics 2006;124():449-54.
2005: Jérôme de Seze; C Lanctin; Christine Lebrun; Irina Malikova; Caroline Papeix; Sandrine Wiertlewski; J Pelletier; Olivier Gout; C Clerc; C Moreau; Gilles Defer; Gilles Edan; Frédéric Dubas; Patrick Vermersch
Idiopathic acute transverse myelitis: application of the recent diagnostic criteria.
Neurology 2005;65(12):1950-3.
2005: Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry Wolinsky
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Annals of neurology 2005;58(6):840-6.
2005: Sean P Morrissey; Emmanuelle Le Page; Gilles Edan
Mitoxantrone in the treatment of multiple sclerosis.
International MS journal / MS Forum 2005;12(3):74-87.
2005: Christian Confavreux; Sandra Vukusic; T Arbizu; Bruno Brochet; Michel Clanet; Gilles Edan; L Kappos; Samy Suissa
[Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response].
Revue neurologique 2005;161(6-7):644-6; author reply 646-7.
2005: Sophie Drapier; Sylvie Raoul; Dominique Drapier; Emmanuelle Leray; François Lallement; Isabelle Rivier; Paul Sauleau; Youenn Lajat; Gilles Edan; Marc Vérin
Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
Journal of neurology 2005;252(5):583-8.
2005: Bruno Stankoff; Emmanuelle Waubant; Christian Confavreux; Gilles Edan; Marc Debouverie; Lucien Rumbach; Thibault Moreau; J Pelletier; Catherine Lubetzki; Michel Clanet
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Neurology 2005;64(7):1139-43.
2005: Sandrine Robineau; Benoit Nicolas; Philippe Gallien; Sabine Petrilli; Aurélie Durufle; Gilles Edan; Pierre Rochcongar
[Eccentric isokinetic strengthening in hamstrings of patients with multiple sclerosis].
Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique 2005;48(1):29-33.
2004: Gilles Edan; Sean P Morrissey; Emmanuelle Le Page
Rationale for the use of mitoxantrone in multiple sclerosis.
Journal of the neurological sciences 2004;223(1):35-9.
2004: Marc Debouverie; N Vandenberghe; Sean P Morrissey; René Anxionnat; S Pittion-Vouyovitch; Hervé Vespignani; Gilles Edan
Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):407-12.
2004: David Laplaud; Catherine Ruiz; Sandrine Wiertlewski; Sophie Brouard; Laureline Berthelot; Marina Guillet; Benoit Melchior; Nicolas Degauque; Gilles Edan; Philippe Brachet; Philippe Damier; Jean-Paul Soulillou
Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
Brain : a journal of neurology 2004;127(Pt 5):981-95.
2004: Gilles Edan
[Aggressive multiple sclerosis. Definition and specific therapeutic indication].
Presse médicale (Paris, France : 1983) 2004;33(3):187-91; discussion 192.
2004: Margaret Pericak-Vance; Jacqueline B Rimmler; Jonathan L Haines; Melissa E Garcia; Jorge R Oksenberg; Lisa F Barcellos; Robin R Lincoln; Stephen L Hauser; Isabelle Cournu-Rebeix; Ariele Azoulay-Cayla; Olivier Lyon-Caen; Bertrand Fontaine; Emmanuelle Duhamel; helene coppin; David Brassat; Marie-Paule Roth; Michel Clanet; Mehdi Alizadeh; Jacqueline Yaouanq; Erwann Quelvennec; Gilbert Semana; Gilles Edan; Marie-Claude Babron; Emmanuelle Genin; Françoise Clerget-Darpoux
Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.
Neurogenetics 2004;5(1):45-8.
2004: Hélène Coppin; M-T Ribouchon; Bertrand Fontaine; Gilles Edan; Michel Clanet; Marie-Paule Roth
A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat.
Genes and immunity 2004;5(1):72-5.
2003: O De Marco; L Riffaud; Jean-François Pinel; Gilles Edan
[Systemic sarcoidosis revealed by acute ataxic sensory polyradiculoneuropathy].
Revue neurologique 2003;159(11):1060-2.
2003: Mehdi Alizadeh; Emmanuelle Génin; Marie-Claude Babron; Brigitte Birebent; Isabelle Cournu-Rebeix; Jacqueline Yaouanq; Stéphane Dréano; Stephen Sawcer; Alastair Compston; Michel Clanet; Gilles Edan; Bertrand Fontaine; Françoise Clerget-Darpoux; Gilbert Semana
Genetic analysis of multiple sclerosis in Europeans: French data.
Journal of neuroimmunology 2003;143(1-2):74-8.
2003: Isabelle Cournu-Rebeix; Emmanuelle Génin; Gaëtan Lesca; Ariele Azoulay-Cayla; N Tubridy; E Noé; Michel Clanet; Gilles Edan; Françoise Clerget-Darpoux; G Sémana; Bertrand Fontaine
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis.
Genes and immunity 2003;4(7):518-23.
2003: Thomas Petzold; Nathalie Barreau; Joanna Ashton-Chess; Gilles Edan; Gwénola Boulday; Jean-Christian Roussel; Ludmilla Le Berre; David Minault; Jean-Paul Soulillou; Gilles Blancho
The effect of mitoxantrone on anti-pig immunization in baboons.
Xenotransplantation 2003;10(5):422-31.
2003: Mehdi Alizadeh; Marie-Claude Babron; Brigitte Birebent; Fumihiko MATSUDA; Erwann Quelvennec; Roland S Liblau; Isabelle Cournu-Rebeix; Patricia Momigliano-Richiardi; Jorge Sequeiros; Jacqueline Yaouanq; Emmanuelle Genin; Alexandre Vasilescu; Héloise Bougerie; Maria Trojano; Berta Martins Silva; Patrícia Maciel; Françoise Clerget-Darpoux; Michel Clanet; Gilles Edan; Bertrand Fontaine; Gilbert Semana
Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Annals of neurology 2003;54(1):119-22.
2003: Frederik Barkhof; Mara Rocca; Gordon Francis; Jan-Hein T M van Waesberghe; Bernard Uitdehaag; Otto R Hommes; Hans-Peter Hartung; Luca Durelli; Gilles Edan; Oscar Fernández; Pierette Seeldrayers; Per Sørensen; Simon Margrie; Marco Rovaris; Giancarlo Comi; Massimo Filippi
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
Annals of neurology 2003;53(6):718-24.
2003: Erwann Quelvennec; Odile Bera; Philippe Cabre; Mehdi Alizadeh; Didier Smadja; F Jugde; Gilles Edan; Gilbert Semana
Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
Tissue antigens 2003;61(2):166-71.
2002: RG Ghalie; E Mauch; Gilles Edan; H P Hartung; R E Gonsette; S Eisenmann; Emmanuelle Le Page; M D Butine; D E De Goodkin
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(5):441-5.
2002: David Brassat; Christian Recher; Emmanuelle Waubant; Emmanuelle Le Page; Françoise Rigal-Huguet; Guy Laurent; Gilles Edan; Michel Clanet
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Neurology 2002;59(6):954-5.
2002: RG Ghalie; Gilles Edan; M Laurent; E Mauch; S Eisenman; H P Hartung; R E Gonsette; M D Butine; D E Goodkin
Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.
Neurology 2002;59(6):909-13.
2002: Grégory Taurin; Véronique Golfier; Jean-François Pinel; Véronique Deburghgraeve; Jean-Yves Poirier; Gilles Edan; Marc Vérin
Choreic syndrome due to Hashimoto's encephalopathy.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):1091-2.
2001: W I McDonald; Alastair Compston; Gilles Edan; Donald Goodkin; Hans-Peter Hartung; Fred D Lublin; Henry McFarland; D W Paty; Chris H Polman; Stephen C Reingold; Magnhild Sandberg-Wollheim; William A Sibley; A Thompson; S van Den Noort; B Y Weinshenker; Jerry Wolinsky
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
Annals of neurology 2001;50(1):121-7.
2001: G Comi; Massimo Filippi; F Barkhof; Luca Durelli; Gilles Edan; O Fernández; H Hartung; P Seeldrayers; Per S Sørensen; Marco Rovaris; V Martinelli; Otto R Hommes
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
Lancet 2001;357(9268):1576-82.
2000: Sophie Drapier; P Kassiotis; I Mourtada; Jean-François Pinel; Gilles Edan
[Multiple cerebral infarcts associated with livedo secondary to anti-cancer therapy with interleukin 2 and interferon alpha].
Revue neurologique 2000;156(10):901-3.
2000: L D Blumhardt; B J Vermeij; M Amato; O Andersen; Gilles Edan; Oscar Fernandez; Massimo Filippi; J Haas; Otto R Hommes; P Rieckmann
A quality network model for the daily care of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2000;6(4):231-6.
2000: Gilles Edan; Marc Coustans
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
Pathologie-biologie 2000;48(2):114-20.
2000: J Reboul; Caroline Mertens; F Levillayer; S Eichenbaum-Voline; T Vilkoren; I Cournu; Marie-Claude Babron; Olivier Lyon-Caen; Françoise Clerget-Darpoux; Gilles Edan; Michel Clanet; Michel Brahic; Jean-François Bureau; Bertrand Fontaine; Roland S Liblau
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Journal of neuroimmunology 2000;102(1):107-12.
1999: Gilles Edan; Marc Coustans
[Evolution and surveillance of multiple sclerosis].
La Revue du praticien 1999;49(17):1866-71.
1999: David Brassat; C Azais-Vuillemin; Jacqueline Yaouanq; Gilbert Semana; J Reboul; I Cournu; Caroline Mertens; Gilles Edan; Olivier Lyon-Caen; Michel Clanet; Bertrand Fontaine
Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.
Neurology 1999;52(8):1632-6.
1998: Caroline Mertens; David Brassat; J Reboul; S Eichenbaum-Voline; C Vuillemin-Azais; I Cournu; Marie-Claude Babron; Gilbert Semana; Gilles Edan; Michel Clanet; Françoise Clerget-Darpoux; Anne Baron-Van Evercooren; Olivier Lyon-Caen; Roland S Liblau; Bertrand Fontaine
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics Group.
Neurology 1998;51(3):748-53.
1998: Brigitte Birebent; Gilbert Semana; A Commeurec; Gilles Edan; B Genetet; Noëlle Genetet
TCR repertoire and cytokine profiles of cerebrospinal fluid- and peripheral blood-derived T lymphocytes from patients with multiple sclerosis.
Journal of neuroscience research 1998;51(6):759-70.
1997: J F Gautier; B Cahagne; Gilles Edan; N Balarac; S Halimi; H Allannic
[Peripheral diabetic neuropathy. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].
Diabetes & metabolism 1997;23(4):335-42.
1997: Gilbert Semana; Jacqueline Yaouanq; Mehdi Alizadeh; M Clanet; Gilles Edan
Interleukin-1 receptor antagonist gene in multiple sclerosis.
Lancet 1997;349(9050):476.
1997: Gilles Edan; D Miller; Michel Clanet; Christian Confavreux; Olivier Lyon-Caen; C Lubetzki; Bruno Brochet; Isabelle Berry; Y Rolland; J C Froment; Emmanuel Alain Cabanis; Marie-Thérèse Iba-Zizen; J M Gandon; H M Lai; Ivan Moseley; O Sabouraud
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Journal of neurology, neurosurgery, and psychiatry 1997;62(2):112-8.
1995: H Moins-Teisserenc; Gilbert Semana; Mehdi Alizadeh; Pascale Loiseau; V Bobrynina; I Deschamps; Gilles Edan; Brigitte Birebent; B Genetet; O Sabouraud
TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis.
Human immunology 1995;42(3):195-202.
1991: Gilles Edan; O Sabouraud
[Benign forms of multiple sclerosis].
La Revue du praticien 1991;41(20):1904-7.
1991: Gilles Edan; M Madigand; M Merienne; G Morel; O Sabouraud; D Salmon; Gilbert Semana; R Fauchet
[A focus of multiple sclerosis in Bretagne: HLA markers and evaluation of consanguinity].
Revue neurologique 1991;147(8-9):595-9.
1990: Jean-Yves Poirier; Annick Moisan; J Le Cloirec; C Siemen; Jacqueline Yaouanq; Gilles Edan; J Y Herry
Renal scintigraphy in insulin-dependent diabetes mellitus: early glomerular and urologic dysfunction.
The Journal of diabetic complications 1990;4(3):113-8.
1989: O Sabouraud; Gilles Edan
[Immunotherapy of multiple sclerosis].
La Revue du praticien 1989;39(10):858-62.
1989: Gilles Edan; Catherine Massart; B Hody; Jean-Yves Poirier; M Lé Reun; J P Hespel; G Leclech; M Simon
Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
BMJ (Clinical research ed.) 1989;298(6670):359-61.
1988: Catherine Massart; B Hody; D Condé; G Leclech; Gilles Edan; M Nicol
Functional properties of human thyroid follicles cultured within collagen gel.
Molecular and cellular endocrinology 1988;56(3):227-34.
1988: M Laurent; Gilles Edan; Catherine Massart; Y Biron; A Le Helloco; P Druelles
[Prevalence of dysthyroidism during treatment with amiodarone].
Presse médicale (Paris, France : 1983) 1988;17(2):79.
1987: H Allannic; Noëlle Genetet; Gilles Edan; G Merdrignac; M Simon; B Genetet
[Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
Pathologie-biologie 1987;35(10):1333-8.
1987: M Simon; L Le Mignon; R Fauchet; Jacqueline Yaouanq; Véronique David; Gilles Edan; M Bourel
A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.
American journal of human genetics 1987;41(2):89-105.
1986: Catherine Massart; B Hody; L Mouchel; Gilles Edan; M Nicol
Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease.
Clinical chemistry 1986;32(7):1332-5.
1984: Gilles Edan; Patrick Bourguet; P Delaval; J Y Herry
Gallium-67 imaging in muscular sarcoidosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(7):776-8.
1984: M Simon; L Le Mignon; Gilles Edan; M Le Reun; J P Hespel
[So-called "other types" of diabetes: chronic pancreatitis and hemochromatosis].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1984;():85-114.
1983: L Le Mignon; M Simon; R Fauchet; Gilles Edan; M Le Reun; P Brissot; B Genetet; M Bourel
An HLA-All association with the hemochromatosis allele?
Clinical genetics 1983;24(3):171-6.
1983: Gilles Edan; Noëlle Genetet; M Le Reun; J P Hespel; B Genetet; M Simon
[Peripheral distribution of lymphocyte subpopulations in Basedow's disease. Decrease in suppressor T-lymphocytes].
Presse médicale (Paris, France : 1983) 1983;12(9):557-60.
1981: M Simon; J P Hespel; P Brissot; R Fauchet; Gilles Edan; M Le Reun; L Le Mignon; B Genetet; M Bourel
[Hemochromatosis].
Annales de médecine interne 1981;132(6):413-33.
1981: M Simon; J P Hespel; P Brissot; R Fauchet; M Le Reun; Gilles Edan; L Le Mignon; B Genetet; M Bourel
[Diagnosis of idiopathic hemochromatosis in 1981].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1981;():187-96.